SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences (SLS) is highly trending amidst intense community discussion, largely driven by its ability to hold above the critical $5 mark, seen as a gateway for broader institutional interest. Investors are focused on the promising potential of its GPS immunotherapy to transform AML treatment, sparking widespread speculation about a significant revaluation or a potential buyout. This fervor is further amplified by exceptionally high borrow fees and persistent short squeeze narratives among traders.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain and as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is experiencing significant community interest, largely driven by its availability on Robinhood and increasing anticipation for the Goliath Mainnet. Investors are actively discussing its potential for institutional adoption and enhanced real-world utility, with many viewing the Binance Futures delisting as a positive catalyst for organic price discovery. The broader crypto market's altcoin season narrative also contributes to bullish sentiment around XCN.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing heightened scrutiny as NVIDIA significantly expands into autonomous driving and humanoid robotics, directly challenging the core growth narratives underpinning TSLA's valuation. Community discussion is sharply divided, with bulls emphasizing Tesla's long-term AI and energy potential, while bears highlight intensified competition, concerns over EV sales, unfulfilled FSD promises, and a recent reiteration of a "Sell" rating by UBS.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is highly discussed amid recent analyst downgrades and an expanded FTC lawsuit concerning its subscription program, sparking debate over its near-term outlook. While some express caution about increasing autonomous vehicle competition, many investors emphasize Uber's robust financials, vast global network, and strategic AV partnerships, believing it is well-positioned to integrate robotaxis and lead the evolving mobility landscape.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPDR S&P 500 ETF Trust (SPY) is trending as market participants react to recent geopolitical developments surrounding Venezuela, with many attributing recent market rallies to the situation. While some in the community cheer the market's "ATH incoming" momentum and anticipate further gains from upcoming earnings and AI sector strength, others express skepticism, warning of a "bull trap" amidst concerns over dollar stability and underlying economic fragilities. The ongoing conversation highlights a stark divide between those expecting new all-time highs and those bracing for a potential correction.

Aeva Technologies, Inc. develops sensing paradigm for autonomous vehicles and robotics. The firm offers drones, robotics, vehicle technology, and virtual and augmented reality products. The company was founded by Soroush Salehian Dardashti and Mina Rezk in 2017 and is headquartered in Mountain View, CA.

Aeva Technologies Inc

Aeva Technologies is prominently trending after announcing a partnership with NVIDIA to integrate its 4D LiDAR as a reference sensor within the NVIDIA DRIVE Hyperion platform ecosystem. This collaboration is widely regarded by the community as a significant validation, fueling discussions about strong market momentum and Aeva's strengthening position in the autonomous vehicle and broader LiDAR sectors.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is actively discussed following recent U.S. action in Venezuela, which included the capture of Nicolas Maduro. The community is polarized, with supporters hailing it as a bold geopolitical move by Donald Trump with potential benefits related to oil and American influence, while critics view it as an illegal intervention and a distraction from other issues. This event is driving significant market sentiment for DJT, given its direct ties to Trump.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amid a strong market rally, fueled by positive reactions to US geopolitical action in Venezuela impacting oil markets and continued optimism surrounding advancements from major AI chipmakers. While many investors see this as a sustainable climb, others express concern about market fragility and institutional selling masking underlying risks.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc. is experiencing a surge in activity following news of its additive manufactured fuel tank, signaling innovation in spacecraft design and production. This immediate catalyst is fueling intense community discussion around potential short squeeze dynamics, given reported high short interest and a recent private placement. Broader enthusiasm for the space sector is amplifying investor focus on the company's future prospects.

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.

Zenas Biopharma Inc.

Zenas BioPharma is trending following its Phase 3 trial results for obexelimab in IgG4-RD. Despite meeting primary endpoints, the community is debating a significant share price drop, attributing it to efficacy comparisons against competitors and a missed milestone payment. Many investors see this as an oversold buying opportunity, while others anticipate continued volatility for this biotech name.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CarMax (KMX.N) is well-positioned to capture greater market share in the used car sector, supported by its omnichannel platform, a stable pricing environment, and rising demand for late-model used vehicles, according to Wedbush.According to a report in MT&nbsp;Newswires, the brokerage said CarMax remains confident in its growth prospects, even after withdrawing its long-term targets due to macroeconomic uncertainty.Wedbush noted that used car store sales picked up in March and April, driven by consumer concerns over the potential rise in prices of new vehicles from tariffs.It added that CarMax’s focus on newer used models and operational efficiency makes it well-suited to benefit from the shift.Earlier this month, CarMax&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/carmax-shares-dive-on-weak-q4-print/chfrOOqRb93">reported</a> fourth-quarter profit and car sales that missed analyst estimates.The company also removed the timeline for some of its long-term targets, such as selling more than 2 million retail and wholesale units annually between fiscal 2026 and 2030.Wedbush said while tariffs could raise parts costs, the overall impact on reconditioning expenses is limited, and CarMax is largely shielded from supply disruptions as it sources most inventory independently.Wedbush maintained its ‘Outperform’ rating on CarMax, with a price target of $90, implying an over 44% upside from the last closing price.On Stocktwits, the retail sentiment jumped to 'Neutral' from 'Bearish' a day ago.<figure class="image"><img style="aspect-ratio:815/188;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_22_at_8_29_08_AM_png_1e5be06519.webp" alt="Screenshot 2025-04-22 at 8.29.08 AM.png" width="815" height="188"><figcaption>KMX sentiment and message volume as of April 21 | Source: Stocktwits</figcaption></figure>Users noted that as tariffs drive up prices, more consumers are expected to turn to used cars—making it a logical time to load up on CarMax shares.<stembedurl>https://stocktwits.com/1of402Phase2TrialUSA/message/611933545</stembedurl><stembedurl>https://stocktwits.com/Stockninja1980/message/611816401</stembedurl>CarMax&nbsp;<a href="https://stocktwits.com/symbol/KMX">stock</a> is down 23.8% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A view of a CarMax dealership on April 10, 2025 in Santa Rosa, California. (Photo by Justin Sullivan/Getty Images)

CarMax Well Positioned For Growth, Says Wedbush: Retail Sentiment Improves

Wedbush said while tariffs could raise parts costs, the overall impact on reconditioning expenses is limited, and CarMax is largely shielded from supply disruptions as it sources most inventory independently.

Equity

Wedbush said while tariffs could raise parts costs, the overall impact on reconditioning expenses is limited, and CarMax is largely shielded from supply disruptions as it sources most inventory independently.


CarMax Inc (KMX) shares fell 17% on Thursday after the used car retailer's fourth-quarter results largely missed expectations.Adjusted profit was $0.64 per share for the quarter ended Feb. 28, below estimated $0.65 per share, according to Reuters/LSEG.Revenue grew 6.7% to $6 billion, narrowly beating estimates of $5.9 billion. However, the number of cars sold, 301,811, was below analysts' expectations of 312,800.CarMax is the largest used car retailer in the United States, operating online and through its over 250 centers nationwide.Shares, which saw their worst decline since September 2022, were also weighed by the company's decision to remove timelines associated with certain long-term goals, "given the potential impact of broader macro factors."President Donald Trump has raised tariffs on imports from all major countries.&nbsp;Although some of the&nbsp;levies have been paused and will likely be renegotiated, companies across industries are bracing for higher prices and disruptions in their supply chains.On Stocktwits, retail sentiment held in the 'bullish' territory, and message volume jumped to 'extremely high' from a day earlier.<figure class="image"><img style="aspect-ratio:806/189;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_11_at_12_24_26_PM_png_0c885a722e.webp" alt="Screenshot 2025-04-11 at 12.24.26 PM.png" width="806" height="189"><figcaption>KMX sentiment and message volume as of April 10 | Source: Stocktwits</figcaption></figure>One user said that as automobile prices are expected to rise, a large portion of buyers might turn to used cars, thus benefiting CarMax.<stembedurl>https://stocktwits.com/powellpnd/message/611238153</stembedurl>Another user said the stock could go above $75&nbsp;if&nbsp;major U.S. banks report strong results on Friday.<stembedurl>https://stocktwits.com/profit_guru/message/611267923</stembedurl>KMX shares closed at $66.45 on Thursday. They are down 18.7% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

CarMax Shares Dive On Weak Q4 Print, But Retail Bets Trump Tariffs Will Rev Up Used Car Demand  

Stock fell 17%, its worst single-day decline since September 2022.

Shares of Helen of Troy Ltd. (HELE) were up nearly 1% on Wednesday after the maker of branded beauty, wellness, and household products reported upbeat second-quarter earnings, even as it drew a lukewarm reaction from retail.Consolidated net sales revenue fell 3.5% to $474.2 million, reflecting a decline in the sale of hair appliances, air purifiers, and humidifiers, but beat analyst estimates of $458.85 million.Net income fell to $17 million from $27.4 million a year earlier. However, adjusted earnings per share came in at $1.21, beating expectations of $1.05.“Despite persistent macro headwinds, we achieved early results on our efforts to 'Reset and Revitalize' our business, driven by improved brand fundamentals, optimized marketing and innovation, and expanded distribution,” said CEO Noel Geoffroy.<figure class="image"><a href="https://stocktwits.com/symbol/HELE"><img style="aspect-ratio:1302/366;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_09_at_5_44_24_PM_5dd42a3512.png" alt="Screenshot Caption: HELE stock’s sentiment meter as of 8:14 am ET on Oct. 09, 2024. | Source: Stocktwits" width="1302" height="366"></a><figcaption>Screenshot Caption: HELE stock’s sentiment meter as of &nbsp;8:14 am ET on Oct. 09, 2024. | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment for HELE following the results edged up into ‘neutral’ (50/100) territory from ‘bearish’ a day ago.<stembedurl>https://stocktwits.com/bananex/message/588419541</stembedurl>The maker of household and beauty products such as Vicks, Braun, and Revlon also reaffirmed its full-year outlook for net sales, adjusted EPS, and adjusted EBITDA.&nbsp;It expects its fiscal 2025 sales to fall between $1.885 billion and $1.935 billion, a decline of 6.0% to 3.5% that it attributes to continuing inflation and softness in consumer spending. &nbsp;It expects adjusted EPS to be between $7 and $7.50, and adjusted Ebitda between $287 million and $297 million.&nbsp;HELE’s stock is down 49% year-to-date.&nbsp;

Helen Of Troy Stock Inches Up After Q2 Earnings Beat Estimates, Retail Sentiment Remains Lukewarm

The maker of household and beauty products such as Vicks, Braun, and Revlon also reaffirmed its full-year outlook for net sales, adjusted EPS, and adjusted EBITDA

Helen Of Troy Stock Inches Up After Q2 Earnings Beat, Retail Sentiment Remains Lukewarm

The maker of household and beauty products such as Vicks, Braun, and Revlon also reaffirmed its full-year outlook for net sales, adjusted EPS, and adjusted EBITDA



U.S. stocks closed mixed Tuesday, with the Dow Jones rising ahead of key earnings and Fed decisions. Before the opening bell on Wednesday, Faraday Future, Nvidia, and VBI Vaccines are drawing significant market attention from the list of most actively traded stocks.Faraday Future Intelligent Electric Inc. (FFIE): Faraday Future stock surged over 21% to $0.38 pre-market after regaining Nasdaq compliance. The EV-maker reported a reduced operating loss of $43.60 million in Q1 from $95.80 million a year ago, and operating expenses fell from $95.80 million to $22.90 million.&nbsp;Last week's Investor Community Day also boosted sentiment. Short interest has dropped to 7.76% from the start of the year. Stocktwits sentiment improved from bearish to neutral (48/100).<figure class="image"><a href="https://stocktwits.com/symbol/FFIE"><img style="aspect-ratio:1308/310;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/FFIE_premakret_sentiment_and_message_score_Jul_31_35799e547d.png" alt="FFIE premakret sentiment and message score Jul 31.png" width="1308" height="310"></a><figcaption>FFIE premarket sentiment and message score Jul 31</figcaption></figure>Nvidia Corp. (NVDA): Nvidia shares are up alongside other chip stocks premarket, likely due to AMD's strong Q2 and whispers of potential new export rules benefiting chipmakers. The Biden administration is reportedly contemplating tweaking a rule on foreign chip equipment exports, which could exempt Japan, the Netherlands, and South Korea.Stocktwits data showed that NVDA’s retail following turned more cheerful on this development, as the sentiment score flipped from neutral a day earlier to extremely bullish (85/100) amid high message volumes. Nvidia is due to report Q2 results on Aug. 28 after market close.<figure class="image"><a href="https://stocktwits.com/symbol/NVDA"><img style="aspect-ratio:1314/308;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/NVDA_premakret_sentiment_and_message_score_Jul_31_40f1f1a154.png" alt="NVDA premakret sentiment and message score Jul 31.png" width="1314" height="308"></a><figcaption>NVDA premarket sentiment and message score Jul 31</figcaption></figure> VBI Vaccines Inc. (VBIV): VBI Vaccines rose nearly 3% pre-market after crashing over 77% in the previous session following the biopharma company's bankruptcy plan and asset sale announcements. It is seeking creditor protection in Canada and expecting to be delisted from the Nasdaq.The firm also intends to file for Chapter 15 bankruptcy in the U.S. Stocktwits sentiment reflected investors’ gloom as retail sentiment hit extremely bearish levels (4/100), the lowest this year. At the same time, message volumes reached a 2024 peak at 'extremely high' (97/100) levels.<figure class="image"><a href="https://stocktwits.com/symbol/VBIV"><img style="aspect-ratio:1312/304;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/VBIV_premakret_sentiment_and_message_score_Jul_31_f4d2586afe.png" alt="VBIV premakret sentiment and message score Jul 31.png" width="1312" height="304"></a><figcaption>VBIV premarket sentiment and message score Jul 31</figcaption></figure>

Pre-Market Movers: Retail's Pulse On Faraday Future, Nvidia and VBI Vaccines

EV-maker Faraday Future had some pleasing news for investors, as shares rocketed before the bell. Nvidia, meanwhile, rode on the cheer surrounding a rival’s strong earnings. But for VBI Vaccines, it has come down to a fight for survival.

Wednesday Pre-Market Movers: What’s Retail Pulse On Faraday Future, Nvidia and VBI Vaccines?

EV-maker Faraday Future had some pleasing news for investors, as shares rocketed before the bell. Nvidia, meanwhile, rode on the cheer surrounding a rival’s strong earnings. But for VBI Vaccines, it has come down to a fight for survival.


VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601. It also develops an enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on April 9, 1965 and is headquartered in Cambridge, MA.

VBI Vaccines Inc.

Physical AI Infrastructure

Power & Energy to Support Growth

Healthcare Value & Innovation

Other – Comment Below

As markets head into 2026, investors are debating whether the next phase favors speculation or real-world execution. With capital rotating toward infrastructure, energy, and undervalued sectors like healthcare, which area do you think will matter most for portfolios in the year ahead?

Which Theme Will Matter Most for Portfolios in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '24	-$0.32	--	--	N/A
Q1 '24	-$0.53	-$0.55	-3.77%	MISSED

VBIV
VBI Vaccines Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '24

Historical Earnings

Latest VBIV News

VBIVVBI Vaccines Inc.